PLEURAL MESOTHELIOMAS
Clinical trials for PLEURAL MESOTHELIOMAS explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMAS trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stall rare lung cancer
Disease control Recruiting nowThis study tests whether adding an experimental immunotherapy (fianlimab) to standard treatment (cemiplimab plus chemotherapy) can better control pleural mesothelioma, a rare and aggressive cancer of the lung lining. About 126 people who have not yet been treated will receive one…
Matched conditions: PLEURAL MESOTHELIOMAS
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for mesothelioma: drug targets cancer from two angles
Disease control Recruiting nowThis phase 2 trial tests a drug called ivonescimab in 38 people with pleural mesothelioma whose cancer has returned after immunotherapy and chemotherapy. The drug works by blocking blood vessel growth and boosting the immune system to fight cancer. The main goal is to see if the …
Matched conditions: PLEURAL MESOTHELIOMAS
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC